Zentek shares to move from Nasdaq to OTC Markets on Tuesday
Zentek (TSXV:ZEN, NASDAQ:ZTEK) will move its shares from Nasdaq to OTC Markets on September 2, 2026, due to non-compliance with Nasdaq's minimum bid price requirement. The company plans to appeal the delisting. Trading on TSX Venture Exchange remains unaffected. Zentek aims to list on OTCQX Best Market, expecting no material impact on its business.
How this was made
The 30-second read
Why it matters
The delisting reflects Nasdaq's minimum bid price rule; the company seeks OTCQX listing to maintain US market presence.
Market read
Primary relevance to traders holding ZTEK or monitoring micro‑cap compliance risks.
What to watch
Zentek's primary TSXV listing remains unchanged, preserving access for Canadian investors.
Background
Zentek Ltd. is a Canadian IP development firm listed on TSXV (ZEN) and Nasdaq (ZTEK).
Ticker impact
Zentek Ltd. announced its Nasdaq shares will be delisted and move to the OTC Markets on Sep 2, 2026.
Potential short-term decline of 5‑10% as investors adjust to OTC trading.
Loss of Nasdaq listing removes market makers and visibility; OTC markets typically trade at a discount.
Market effects
Highlights compliance risk for other small-cap Nasdaq listings in the tech/materials space.
May affect Canadian TSXV investors who hold ZEN shares, but primary impact is US OTC market.
Limited to niche micro‑cap investors; no broad market effect.
Counterpoint
OTC listing could attract niche investors seeking higher yields, potentially stabilizing price.
Key entities
- CompanyZentek Ltd.
Canadian intellectual property developer moving Nasdaq shares to OTC.



